Department of Internal Medicine and Pathology, Carver College of Medicine, The University of Iowa, Iowa City, IA 52242, USA.
Arthritis Res Ther. 2009;11(3):R79. doi: 10.1186/ar2710. Epub 2009 May 28.
B cells have many different roles in systemic lupus erythematosus (SLE), ranging from autoantigen recognition and processing to effector functions (for example, autoantibody and cytokine secretion). Recent studies have shown that intracellular nucleic acid-sensing receptors, Toll-like receptor (TLR) 7 and TLR9, play an important role in the pathogenesis of SLE. Dual engagement of rheumatoid factor-specific AM14 B cells through the B-cell receptor (BCR) and TLR7/9 results in marked proliferation of autoimmune B cells. Thus, strategies to preferentially block innate activation through TLRs in autoimmune B cells may be preferred over non-selective B-cell depletion.
We have developed a new generation of DNA-like compounds named class R inhibitory oligonucleotides (INH-ODNs). We tested their effectiveness in autoimmune B cells and interferon-alpha-producing dendritic cells in vitro and in lupus-prone MRL-Faslpr/lpr mice in vivo.
Class R INH-ODNs have 10- to 30-fold higher inhibitory potency when autoreactive B cells are synergistically activated through the BCR and associated TLR7 or 9 than when stimulation occurs via non-BCR-engaged TLR7/9. Inhibition of TLR9 requires the presence of both CCT and GGG triplets in an INH-ODN, whereas the inhibition of the TLR7 pathway appears to be sequence-independent but dependent on the phosphorothioate backbone. This difference was also observed in the MRL-Faslpr/lpr mice in vivo, where the prototypic class R INH-ODN was more effective in curtailing abnormal autoantibody secretion and prolonging survival.
The increased potency of class R INH-ODNs for autoreactive B cells and dendritic cells may be beneficial for lupus patients by providing pathway-specific inhibition yet allowing them to generate protective immune response when needed.
B 细胞在系统性红斑狼疮(SLE)中具有多种不同的作用,范围从自身抗原识别和加工到效应功能(例如,自身抗体和细胞因子分泌)。最近的研究表明,细胞内核酸感应受体,Toll 样受体(TLR)7 和 TLR9,在 SLE 的发病机制中起重要作用。类风湿因子特异性 AM14 B 细胞通过 B 细胞受体(BCR)和 TLR7/9 的双重结合导致自身免疫 B 细胞的显著增殖。因此,与非选择性 B 细胞耗竭相比,通过 TLR 在自身免疫 B 细胞中优先阻断先天激活的策略可能是首选。
我们开发了一类新的 DNA 样化合物,命名为类 R 抑制性寡核苷酸(INH-ODN)。我们在体外测试了它们在自身免疫 B 细胞和干扰素-α产生树突状细胞中的有效性,并在狼疮易感 MRL-Faslpr/lpr 小鼠体内进行了测试。
当自身反应性 B 细胞通过 BCR 及其相关的 TLR7 或 9 协同激活时,类 R INH-ODN 的抑制效力比通过非 BCR 结合的 TLR7/9 刺激时高 10 至 30 倍。TLR9 的抑制需要 INH-ODN 中 CCT 和 GGG 三核苷酸的存在,而 TLR7 途径的抑制似乎与序列无关,但依赖于硫代磷酸酯骨架。在体内 MRL-Faslpr/lpr 小鼠中也观察到了这种差异,其中原型类 R INH-ODN 在抑制异常自身抗体分泌和延长生存方面更有效。
类 R INH-ODN 对自身反应性 B 细胞和树突状细胞的效力增加可能对狼疮患者有益,因为它提供了特定途径的抑制作用,但在需要时允许它们产生保护性免疫反应。